2025 FDA Drug Approvals
~600 rows
~140 KB CSV
Updated monthly
United States
2025
Free
Download
About this dataset
Historical dataset of 2025 FDA approvals — NMEs, sNDAs, sBLAs, and biosimilars. Final retrospective version published Q1 2026 after all 2025 PDUFA windows closed.
Schema
| Column | Description | Type |
|---|---|---|
drug_id | Drug Landscape stable identifier | |
brand_name | Trade name | |
generic_name | Generic name | |
company_name | Sponsor | |
approval_date | Approval date (ISO 8601) | |
therapeutic_area | Therapeutic area |
Sources
Drugs@FDA.
Citation
APA
Drug Landscape. (2026). 2025 FDA Drug Approvals (Version 2026.05) [Data set]. Drug Landscape. https://druglandscape.com/datasets/fda-approvals-2025
BibTeX
@dataset{DrugLandscape2025FDAApprovals,
author = {Drug Landscape},
title = {2025 FDA Drug Approvals},
year = {2026},
version = {2026.05},
publisher = {Drug Landscape},
url = {https://druglandscape.com/datasets/fda-approvals-2025},
note = {~600 rows; source: Drugs@FDA}
}
RIS
TY - DATA T1 - 2025 FDA Drug Approvals AU - Drug Landscape PY - 2026 ET - 2026.05 PB - Drug Landscape UR - https://druglandscape.com/datasets/fda-approvals-2025 ER -
License
Free for any use including commercial, with attribution to Drug Landscape (druglandscape.com). Full terms in our editorial policy.